DE69024951T2 - Unterscheidung zwischen antikörpern gegen htlv-i, htlv-ii oder verwandten retroviren, neue peptide, nachweis von antikörpern und immuntestsätze - Google Patents

Unterscheidung zwischen antikörpern gegen htlv-i, htlv-ii oder verwandten retroviren, neue peptide, nachweis von antikörpern und immuntestsätze

Info

Publication number
DE69024951T2
DE69024951T2 DE69024951T DE69024951T DE69024951T2 DE 69024951 T2 DE69024951 T2 DE 69024951T2 DE 69024951 T DE69024951 T DE 69024951T DE 69024951 T DE69024951 T DE 69024951T DE 69024951 T2 DE69024951 T2 DE 69024951T2
Authority
DE
Germany
Prior art keywords
htlv
antibodies
differentiation
detection
new peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69024951T
Other languages
English (en)
Other versions
DE69024951D1 (de
Inventor
Jonas Blomberg
Ruediger Pipkorn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Replico Medical AB
Original Assignee
Replico Medical AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Medical AB filed Critical Replico Medical AB
Publication of DE69024951D1 publication Critical patent/DE69024951D1/de
Application granted granted Critical
Publication of DE69024951T2 publication Critical patent/DE69024951T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69024951T 1989-03-02 1990-03-02 Unterscheidung zwischen antikörpern gegen htlv-i, htlv-ii oder verwandten retroviren, neue peptide, nachweis von antikörpern und immuntestsätze Expired - Fee Related DE69024951T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8900721A SE8900721D0 (sv) 1989-03-02 1989-03-02 Methods for detection of antibodies to
PCT/SE1990/000139 WO1990010231A1 (en) 1989-03-02 1990-03-02 Discrimination between antibodies against htlv-i, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits

Publications (2)

Publication Number Publication Date
DE69024951D1 DE69024951D1 (de) 1996-02-29
DE69024951T2 true DE69024951T2 (de) 1996-08-01

Family

ID=20375207

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69024951T Expired - Fee Related DE69024951T2 (de) 1989-03-02 1990-03-02 Unterscheidung zwischen antikörpern gegen htlv-i, htlv-ii oder verwandten retroviren, neue peptide, nachweis von antikörpern und immuntestsätze

Country Status (8)

Country Link
US (1) US6242174B1 (de)
EP (1) EP0461193B1 (de)
JP (1) JP3271666B2 (de)
AU (1) AU640921B2 (de)
CA (1) CA2048655C (de)
DE (1) DE69024951T2 (de)
SE (1) SE8900721D0 (de)
WO (1) WO1990010231A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614366A (en) * 1986-12-31 1997-03-25 Genelabs Technologies, Inc. HTLV-I peptide antigens and kit
FI910245A (fi) * 1990-01-24 1991-07-25 United Biomedical Inc Syntetiska peptidkompositioner med immunoreaktivitet mot htlv-antikroppar.
NZ238855A (en) * 1990-07-18 1994-03-25 Iaf Biochem Int Peptides, mixtures thereof and compositions useful for detecting htlv-i and htlv-ii infections
CA2090470A1 (en) * 1990-08-29 1992-03-01 Renu B. Lal Peptide antigens and immunoassays, test kits and vaccines using the same
JPH04164097A (ja) * 1990-10-24 1992-06-09 Kuraray Co Ltd ペプチドおよびその用途
AU8944691A (en) * 1990-10-26 1992-05-26 President And Fellows Of Harvard College Specific detection of antibodies to human t-cell leukemia viruses
EP0677117B1 (de) * 1991-07-10 1999-05-26 Abbott Laboratories Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
AU2412692A (en) * 1991-07-23 1993-02-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Novel peptide antigens and immunoassays, test kits and vaccines using the same
WO1993011431A1 (en) * 1991-11-25 1993-06-10 Baxter Diagnostics Inc. Immunoassay using synthetic htlv-ii peptides
CA2117378C (en) * 1992-02-24 2003-04-15 Steven K. H. Foung Htlv-i/htlv-ii assay and method
SE9202318L (sv) * 1992-08-10 1994-02-11 Replico Medical Ab Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter
US6406841B1 (en) 1993-07-01 2002-06-18 Abbott Laboratories Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides
GB9711148D0 (en) * 1997-05-31 1997-07-23 Peptide Therapeutics Ltd Human MAFA
IL158287A0 (en) * 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59155347A (ja) 1983-02-23 1984-09-04 Japan Found Cancer ヒト白血病ウイルス関連ペプチド
JPS59128366A (ja) 1983-01-07 1984-07-24 Japan Found Cancer ヒト白血病ウイルス関連ペプチド
CA1262014A (en) * 1983-01-07 1989-09-26 Mitsuaki Yoshida Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
AU600224B2 (en) * 1984-09-19 1990-08-09 Regents Of The University Of California, The Retroviral polypeptides associated with human cellular transformation
JP2501569B2 (ja) * 1986-11-14 1996-05-29 協和醗酵工業株式会社 抗成人ｔ細胞白血病ウイルス抗体の検出法
US4833071A (en) 1987-01-09 1989-05-23 United Biomedical, Inc. Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
US5039604A (en) * 1987-08-21 1991-08-13 Cellular Products, Inc. Test device and method of preparing same, assay kit and method for the simultaneous detection of two HTLV or HIV antibodies
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
EP0330359A3 (de) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
US5017687A (en) * 1988-03-10 1991-05-21 Virovahl, S.A. Peptides for the detection of HTLV-1 infection

Also Published As

Publication number Publication date
CA2048655A1 (en) 1990-09-03
CA2048655C (en) 2000-03-21
AU5283490A (en) 1990-09-26
JPH04507286A (ja) 1992-12-17
DE69024951D1 (de) 1996-02-29
EP0461193B1 (de) 1996-01-17
AU640921B2 (en) 1993-09-09
WO1990010231A1 (en) 1990-09-07
EP0461193A1 (de) 1991-12-18
JP3271666B2 (ja) 2002-04-02
US6242174B1 (en) 2001-06-05
SE8900721D0 (sv) 1989-03-02

Similar Documents

Publication Publication Date Title
DE69024951T2 (de) Unterscheidung zwischen antikörpern gegen htlv-i, htlv-ii oder verwandten retroviren, neue peptide, nachweis von antikörpern und immuntestsätze
DE69006306T2 (de) Synthetische peptide des konjugates von ubiquitin und histon h2a.
ATE121192T1 (de) Nachweis von chemikalien mittels immuntestverfahren.
DE3788626T2 (de) Nor-Statin und Nor-Cyclostatin enthaltende Polypeptide.
DE69008262D1 (de) Trennung von Gasmischungen.
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
ES2194017T3 (es) Proceso para producir polipeptidos, proteinas o peptidos hidrofobos.
DE69126577D1 (de) Antigenes Peptid zum Nachweis von Anti-Hepatitis-C-Virus-Antikörpern und dessen Verwendung
DE3887053T4 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.
DE69125161D1 (de) Synthetische peptide und mischungen davon zum nachweis der gegen hiv-gerichteten antikörper
DE69110891D1 (de) Peptide und analoge und mischungen davon zum nachweis der gegen die viren htlv-1 und htlv-ii gerichteten antikörper.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
DE68926245T2 (de) Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten
DE3674567D1 (de) Verbesserungen in bezug auf nachweis von viren und antikoerpern.
ATE118616T1 (de) Immunologischer nachweis von atrazin und atrazinderivaten.
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
DE3886032T2 (de) Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren.
DK604589D0 (da) Peptider, og analysesaet med indhold af saadanne forbindelser
DK604689A (da) Peptider, og analysesaet med indhold af saadanne forbindelser
DE69531955D1 (de) PROGRESSIVE ANDERUNG VON SIGNAL-PROTEINEN UND PEPTIDEn UND DIE HERGESTELLTEN SUPERAGONISTEN UND ANTAGONISTEN
IL90553A0 (en) Protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses
DE3853832D1 (de) Htlv-i-peptid-antigen und testverfahren.
DE69124768T2 (de) Bestimmung von Substanzen mittels durchfluss Zytometrie
ATE122569T1 (de) Htlv-i-peptid-antigen und testverfahren.
ATE95192T1 (de) T-zellen-lymphotrophisches virus-protein und testverfahren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee